Permira is allegedly reconsidering its plans to exit its investment in Dr Martens, with discussions to restart in the next few months about a potential sale or initial public offering (IPO) of the company. In 2019, U.S. headquartered private equity firm Carlyle Group was said to be considering making an offer to acquire the UK based footwear brand. The talks didn’t result in an agreement and were followed by the Covid-19 outbreak.

Source: Bloomberg